atai Life Sciences Advances VLS-01, A Novel DMT-Based Treatment

LOS ANGELES- atai Life Sciences a biotechnology company specializing in mental health treatments, is making strides in the...

New Mexico Advances Psilocybin Research with Memorial Legislation

-LOS ANGELES- In a significant move toward exploring alternative therapeutic treatments, New Mexico Governor Michelle Lujan Grisham has...

Clinical Trial Explores Psychedelic Treatment for Depression

LOS ANGELES- In a move within the field of psychiatric treatment, MindBio Therapeutics Corp. has announced the launch of its Phase 2B clinical trial, investigating the potential of psychedelics...

Indiana’s Pioneering Psilocybin Research Bill Awaits Governor’s Approval

LOS ANGELES- In a groundbreaking legislative move, Indiana stands on the precipice of advancing psilocybin research, following the final approval of a bill aimed at exploring the substance's potential...
spot_img

Justice

Capital

HighlyCapitalized TV

Insights

Arizona Embarks on Psychedelic Therapy Frontier with Psilocybin Service Center Legislation

LOS ANGELES- In a significant step towards the integration...

Filament Health Corp. Gains FDA Approval for Psilocybin Clinical Trials

LOS ANGELES- The U.S. Food and Drug Administration (FDA)...

Broad Support in Canada for Psilocybin Use in Palliative Care, New Study Reveals

LOS ANGELES — A recent Canadian study, published in the...

AlphaFold: AI’s Role in the Future of Psychedelic Drug Development

LOS ANGELES- In the realm of pharmaceutical research, a...

Filament Health Achieves Milestone with First Botanical Psilocybin Export to Australia

NEW YORK – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA:...

VA to Explore Psychedelics for PTSD and Depression

LOS ANGELES- In a groundbreaking move, the Department of...
spot_img

Become a member

Each template in our ever growing studio library can be added and moved around within any page effortlessly with one click. Combine them, rearrange them and customize them further as much as you desire.

All Latest Articles

Numinus Wellness Secures $6 Million in Public Offering to Fuel Psychedelic-Assisted Therapy Initiatives

LOS ANGELES- Numinus Wellness, a Vancouver-based healthcare company specializing in the innovative field of psychedelic-assisted therapies, has announced the successful completion of a significant...

FSD Pharma Announces Market Offering Agreement to Fund Research and Development

NEW YORK- FSD Pharma a biopharmaceutical company focused on developing a diverse portfolio of innovative assets and biotechnological solutions, has unveiled a strategic market...

Clearmind Medicine Inc. Advances Psychedelic Therapeutics with New Patent Applications

NEW YORK– Clearmind Medicine Inc. a biotech firm dedicated to the discovery and development of novel psychedelic-derived therapeutics, has taken significant steps to enhance...

MindBio Therapeutics Announces Completion of Groundbreaking Phase 2a LSD Microdose Trial

LOS ANGELES- In a significant advancement for psychiatric medicine, MindBio Therapeutics Corp., a pioneering biopharmaceutical company, has announced the successful completion of its Phase...

Silo Pharma Advances in Ketamine-Based Treatment for Chronic Pain

LOS ANGELES— In a significant stride toward innovative treatment for chronic pain conditions, Silo Pharma, Inc. (Nasdaq: SILO), a biopharmaceutical company in its developmental...

PharmaDrug Inc. Completes Private Placement to Bolster Corporate Initiatives

LOS ANGELES- a specialty pharmaceutical company, announce the successful completion of its previously disclosed non-brokered private placement, raising total gross proceeds of $326,000. In this...

Subscribe